Tamara Senikidze

Jones Day

+ Follow Contact

Latest Posts › Adverse Events

Share:

EMA Green Lights New EudraVigilance System for Adverse Reactions, Pharmaceutical & Medical Device Update, Vol. IV, Issue III

On May 22, 2017, the European Medicines Agency ("EMA") announced the full functionality of the new EudraVigilance system for the collection and monitoring of suspected adverse reactions with medicinal products that are...more

7/1/2017 / Adverse Events , Clinical Trials , Databases , EU , European Economic Area (EEA) , European Medicines Agency (EMA) , Pharmaceutical Industry , Risk Assessment , World Health Organization

1 Results

View per page

Page: of 1

Tamara Senikidze

Jones Day

Popular Topics by This Author

Latest Posts › Adverse Events

EMA Green Lights New EudraVigilance System for Adverse Reactions, Pharmaceutical & Medical Device Update, Vol. IV, Issue III

"My best business intelligence, in one easy email…"